It was a privilege to meet Alexandre Lourenço, President of the Portuguese Association of Hospital Managers, at the ECCO 2019 European Cancer Summit in Brussels to discuss his expert opinion on how we can introduce novel therapies into use in a sustainable way.
1. To what extent is access to innovative cancer treatments limited in Portugal and is there a similar issue in other European nations? (0:08)
2. Is restricted access to some cancer treatments resulting in poor patient outcomes, increased morbidity and earlier deaths? (0:44)
3. Treatments such as chimeric antigen receptor (CAR) T-cells are highly effective in the treatment of some cancers. Could access to this and other novel treatments be increased through increased funding and/or improved technologies? (1:19)
4. Can you describe the key aims of the Primary Care P4P initiative in Portugal and how it could improve primary care in cancer? (1:50)
5. The Association of European Cancer Leagues (ECL) Access to Medicines Taskforce and other organisations aim to improve the availability of new cancer treatments. What progress have these organisations made towards this goal and what remains to be done? (3:00)
Alexandre Lourenço has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European CanCer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
Share this Video
Related Videos In Policy
Kim Benstead, European Cancer Summit, 2022: Technical advances in cancer training in Europe
Dr Kim Benstead (Gloucestershire NHS Foundation Trust, London, UK) discusses the most recent improvements in cancer training in Europe, including the major shift online due to the COVID-19 pandemic, and the importance of creating simulations and more interactive training. Questions What have been the most important technological advances in cancer training in Europe? (00:26-01:24) How […]
Kim Benstead, European Cancer Summit, 2022: The INTERACT-EUROPE training programme
Dr Kim Benstead (Gloucestershire NHS Foundation Trust, London, UK) discusses the most recent developments to the European Beating Cancer Plan, including the importance of multidisciplinary in cancer workforces, and the need for quality training schemes. As Chair of INTERACT-EUROPE, she shares her hopes for the new, two-phase training programme to optimise cancer care not only […]
Ajay Aggarwal, European Cancer Summit 2022: Ensuring a better future for young cancer professionals
Dr Ajay Aggarwal (Guy’s and St Thomas’ NHS Trust, London, UK) discusses the need to further develop our future cancer workforce and provide young professionals with enough resources for research but also a strong understanding of what it is to deliver quality cancer care. He also expresses four needs for improvement in current health systems; […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!